Partech raises fourth seed fund • TechCrunch
French VC firm Partech has closed another seed fund dedicated to early-stage tech startups —
fourth
Bolt Biotherapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights
– Upsized IPO in February 2021 raised $264.5 million in gross proceeds plus Series C
BiomX Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
NESS ZIONA, Israel–(BUSINESS WIRE)–Mar 31, 2021– BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”),
XpresSpa Group Provides Business Update and Announces Fourth Quarter 2020 Financial Results
Eleven XpresCheck Wellness Centers Currently Operating with Two Additional Locations to Open Soon Positioned to
Cousins characterize fourth era of Murphy loved ones in funeral dwelling enterprise
CHAGRIN FALLS, Ohio – Matt Murphy and Denny Murphy grew up all over the funeral
AgeX Therapeutics Reports Fourth Quarter and Annual 2020 Financial Results and Provides Business Update
ALAMEDA, Calif.–(BUSINESS WIRE)–AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for
Frequency Therapeutics Supplies Enterprise Updates and Reports Fourth Quarter and Full Year 2020 Fiscal Results
WOBURN, Mass.–(Enterprise WIRE)–Mar 29, 2021– Frequency Therapeutics, Inc. (Nasdaq: FREQ), a medical-stage biotechnology organization concentrated
Cousins stand for fourth generation of Murphy spouse and children in funeral dwelling small business
CHAGRIN FALLS, Ohio — Matt Murphy and Denny Murphy grew up all-around the funeral household
Cousins depict fourth generation of Murphy household in funeral household enterprise
CHAGRIN FALLS, Ohio – Matt Murphy and Denny Murphy grew up all over the funeral
Harmony Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results and Business Updates
WAKIX® (pitolisant) Total Revenue of $160 Million for Full-Year 2020; $56 Million for Fourth Quarter
Evolus Reports Fourth Quarter and Full Year 2020 Results and Provides Business Update
Q4 2020 Net Revenue $20.6 Million, Highest Net Revenue Quarter Since Launch of Jeuveau® Pro
Sana Biotechnology Reports Fourth Quarter and 2020 Financial Results and Business Updates
Expects to present data at multiple scientific conferences in 2021 2020 year-end cash position of
Aligos Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights
– Advanced ALG-010133 and ALG-000184 into the clinic – both expected to generate safety and
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides Business Update
Established in vivo genome editing research collaboration and exclusive license agreement with Eli Lilly Reported
Legend Biotech Reports Fourth Quarter and Full Year 2020 Financial Results and Business Update
Legend received approximately $659.8 million in gross proceeds through share capital increases during 2020, including
PLAYSTUDIOS, Inc. Announces Preliminary Fourth Quarter and Full Year 2020 Results Along With Recent Business Highlights
– Fourth Quarter Revenue of $64.0 million and Full Year 2020 Revenue of $269.9 million,
22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and …
Key Business and Financial Highlights 22nd Century has a tremendous global commercial opportunity in the
Histogen Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Business Update
Strengthened Balance Sheet with $25.3 Million of Gross Proceeds from Financings and Warrant Exercises Initiation